RECBIO-B's targeted issuance of domestic shares has been approved by the China Securities Regulatory Commission
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, RECBIO-B announced that on July 23, 2025, the company received the China Securities Regulatory Commission's "Approval on Jiangsu RECBIO Biotechnology Co., Ltd. to Issue Stocks to Specific Objects" (CSRC Permit [2025] No. 1506), and the China Securities Regulatory Commission has approved this issuance
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments